Previous close | 0.0400 |
Open | 0.0500 |
Bid | 0.0400 |
Ask | 0.0500 |
Strike | 45.00 |
Expiry date | 2024-01-19 |
Day's range | 0.0400 - 0.0500 |
Contract range | N/A |
Volume | |
Open interest | 30.75k |
Viatris' broad portfolio gives the business lots of stability and plenty of opportunities -- but is there enough there for the stock to be a great long-term investment?
Moderna (NASDAQ: MRNA) used to be a stock market star, climbing 1,700% from the start of 2020 through July of 2021. Investors liked that, and it clearly showed in the stock performance. After all, the vaccine is Moderna's only product right now, and demand for it has declined.
The fight against COVID-19 isn't over yet, and the two companies remain very much in the battle.